Protease inhibitor and integrase strand transfer inhibitor

This page covers all Protease inhibitor and integrase strand transfer inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV protease and HIV integrase.

Targets

HIV protease and HIV integrase

Phase 3 pipeline (1)

• darunavir/ritonavir QD + raltegravir BID · ANRS, Emerging Infectious Diseases · Infectious Diseases
  Darunavir/ritonavir QD is a protease inhibitor that blocks HIV replication, while raltegravir BID is an integrase strand transfer inhibitor that also blocks HIV replication.